1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MONOPAR THERAPEUTICS INC
Monopar Therapeutics Inc XNAS: MNPR

Monopar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prev...

Read More
49.22 1.56 (3.27%)
1452.68% Gain from 52W Low
22,352
XNAS Volume

XNAS 12 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
4.2 / 100
Momentum Score
Technically Bullish
70.3 / 100
Analyst Price Target
No estimates available

19

S

4

W

5

O

1

T

SWOT Analysis

Monopar Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..